These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8041153)

  • 1. Precursor frequency analysis of bryostatin activated lymphocytes.
    Fleming MD; Barrett SK; Bear HD
    J Surg Res; 1994 Jul; 57(1):74-9. PubMed ID: 8041153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1.
    Tuttle TM; Inge TH; Bethke KP; McCrady CW; Pettit GR; Bear HD
    Cancer Res; 1992 Feb; 52(3):548-53. PubMed ID: 1732041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bryostatin-1 enhances the maturation and antigen-presenting ability of murine and human dendritic cells.
    Do Y; Hegde VL; Nagarkatti PS; Nagarkatti M
    Cancer Res; 2004 Sep; 64(18):6756-65. PubMed ID: 15374994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human T lymphocytes by bryostatin.
    Hess AD; Silanskis MK; Esa AH; Pettit GR; May WS
    J Immunol; 1988 Nov; 141(10):3263-9. PubMed ID: 3263418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bryostatin/ionomycin-activated T cells mediate regression of established tumors.
    Chin CS; Graham LJ; Hamad GG; George KR; Bear HD
    J Surg Res; 2001 Jun; 98(2):108-15. PubMed ID: 11397126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulating properties of a novel series of protein kinase C activators. The bryostatins.
    Trenn G; Pettit GR; Takayama H; Hu-Li J; Sitkovsky MV
    J Immunol; 1988 Jan; 140(2):433-9. PubMed ID: 3257237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
    Teh HS; Yu M
    J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gamma-Interferon plays a key role in T-cell-induced tumor regression.
    Tuttle TM; McCrady CW; Inge TH; Salour M; Bear HD
    Cancer Res; 1993 Feb; 53(4):833-9. PubMed ID: 8428364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C.
    Isakov N; Galron D; Mustelin T; Pettit GR; Altman A
    J Immunol; 1993 Feb; 150(4):1195-204. PubMed ID: 8432975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bryostatin-I: a dendritic cell stimulator for chemokines induction and a promising adjuvant for a peptide based cancer vaccine.
    Yan W; Chen WC; Liu Z; Huang L
    Cytokine; 2010 Dec; 52(3):238-44. PubMed ID: 20869878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the protein kinase C stimulant bryostatin 1 on the proliferation and colony formation of irradiated human T-lymphocytes.
    Sung SJ; Lin PS; Schmidt-Ullrich R; Hall CE; Walters JA; McCrady C; Grant S
    Int J Radiat Biol; 1994 Dec; 66(6):775-83. PubMed ID: 7814976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulator cell requirements for allospecific T cell subsets: specialized accessory cells are required to activate helper but not cytolytic T lymphocyte precursors.
    Czitrom AA; Sunshine GH; Reme T; Ceredig R; Glasebrook AL; Kelso A; MacDonald HR
    J Immunol; 1983 Feb; 130(2):546-50. PubMed ID: 6600241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.
    Reddehase MJ; Keil GM; Koszinowski UH
    J Immunol; 1984 Jan; 132(1):482-9. PubMed ID: 6317749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol dibutyrate and ionomycin improve murine effector cell cytotoxicity.
    Hamby LS; Freeman JW; McGrath PC
    J Surg Res; 1993 Feb; 54(2):115-21. PubMed ID: 8479168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM
    Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limiting dilution analysis of alloreactive cytotoxic precursor cells in aging mice.
    Nordin AA; Collins GD
    J Immunol; 1983 Nov; 131(5):2215-8. PubMed ID: 6226737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells.
    Ohno K; Yoshizawa H; Tsukada H; Takeda T; Yamaguchi Y; Ichikawa K; Maruyama Y; Suzuki Y; Suzuki E; Arakawa M
    J Immunol; 1996 May; 156(10):3875-81. PubMed ID: 8621926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens.
    Carnaud C; Ishizaka ST; Stutman O
    J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bryostatin 1 acts synergistically with interleukin-1 alpha to induce secretion of G-CSF and other cytokines from marrow stromal cells.
    Lilly M; Vo K; Le T; Takahashi G
    Exp Hematol; 1996 Apr; 24(5):613-21. PubMed ID: 8605966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.